Kinase-driven inflammasome resolution: shifting the paradigm for atherosclerosis management

European Heart Journal 2026

View at publisher
Authors: Maurizio Acampa, Riccardo Accioli, Pietro Enea Lazzerini
DOI: 10.1093/eurheartj/ehaf1129
Cited by: 1
References: 12

Abstract

Current inflammatory-modulation strategies and their limitations vs emerging SBK2–NLRP3–axis therapies, against the inflammatory cascade leading to vascular inflammation and atherosclerosis.

Fields of Study & Subjects

Inflammasome and immune disorders Phagocytosis and Immune Regulation Adipokines Inflammation and Metabolic Diseases

Publication details

Journal / source
European Heart Journal
Publisher
Oxford University Press (OUP)
Volume
47
Issue
28
Pages
3797–3799
Publication date
1 January 2026
Language
EN